Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 12,674 | 8,632 | 25,147 | 28,096 | 5,897 |
| Gross Profit | 12,674 | 8,632 | 25,147 | 28,096 | 5,897 |
| Operating Expenses | 54,911 | 57,854 | 46,357 | 47,475 | 45,029 |
| Operating Income | -42,237 | -49,222 | -21,210 | -19,379 | -39,132 |
| Interest Expense | 0 | 0 | 0 | 0 | 657 |
| Other Income | -7,418 | 14,628 | 1,722 | -4,133 | 679 |
| Pre-tax Income | -49,655 | -34,594 | -19,488 | -23,512 | -39,110 |
| Income Tax | 395 | N/A | 0 | 2,500 | 0 |
| Net Income Continuous | -50,050 | -34,594 | -19,488 | -26,012 | -39,110 |
| Net Income | $-50,050 | $-34,594 | $-19,488 | $-26,012 | $-39,110 |
| EPS Basic Total Ops | -8.50 | -5.90 | -3.70 | -5.50 | -8.40 |
| EPS Basic Continuous Ops | -8.52 | -5.82 | -3.72 | -5.54 | -8.41 |
| EPS Diluted Total Ops | -8.50 | -5.90 | -3.70 | -5.50 | -8.40 |
| EPS Diluted Continuous Ops | -8.52 | -5.82 | -3.72 | -5.54 | -8.41 |
| EBITDA(a) | $-42,408 | $-48,868 | $-19,875 | $-17,615 | $-37,259 |